Company intelligence / Profile preview

Haibang Capital

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Haibang Capital (Zhejiang Haibang Investment Management) is a China-based venture capital and private equity manager founded around 2011, with a strong focus on healthcare, biotechnology, medical devices and broader “life and health” sectors, investing mainly in Chinese early- and growth-stage companies.

Industry: Investors

Partnerships

Acts as co‑investor with multiple healthcare-focused funds in China, including Lilly Asia Ventures, WuXi Healthcare Ventures/WuXi AppTec Ventures, China Summit Capital, Guangzhou YUEXIU Industrial Investment Fund, Sungent Bioventure, and others across various healthcare deals.

Beyond the preview

Go deeper on Haibang Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haibang Capital.

Explore the full profile